Heerlen, NL, 07 May 2014, 18:00 CEST
The Annual General Meeting of Shareholders (AGM) took place on Wednesday 7 May 2014 at DSM’s head office in Heerlen, the Netherlands.
The shareholders or shareholder representatives attending the meeting represented 61% of the issued share capital entitled to vote. There is one vote per share and all the resolutions were approved.
The Managing Board elucidated the Annual Report for 2013.
The implementation in 2013 of the remuneration policy for the Managing Board was discussed.
The Financial Statements for 2013 were adopted.
The reserve policy and dividend policy were elucidated.
The dividend per ordinary share to be paid for 2013 being €1.65 was declared. The final dividend (€1.15) to be made available in cash or ordinary shares, at the option of the shareholder was adopted.
The members of the Managing Board were released from liability in respect of their managerial activities; the release relates to the data revealed by the annual accounts and/or otherwise communicated to the General Meeting before the annual accounts were approved.
The members of the Supervisory Board were released from liability in respect of their supervisory role; the release relates to the data revealed by the annual accounts and/or otherwise communicated to the General Meeting before the annual accounts were approved.
Mr. Rolf-Dieter Schwalb was reappointed as member of the Managing Board.
Mrs. Geraldine Matchett was appointed as member of the Managing Board.
Mr. Rob Routs was reappointed as member of the Supervisory Board.
Mr. Tom de Swaan was reappointed as member of the Supervisory Board.
KPMG Accountants NV was appointed as independent auditor for Koninklijke DSM NV.
The period during which the Managing Board is authorized to issue ordinary shares was extended.
The period during which the Managing Board is authorized to limit or exclude the preferential right when issuing ordinary shares was extended.
Authorization was granted to the Managing Board to have the company repurchase own shares.
The meeting resolved to reduce the issued capital by cancellation of own shares up to a maximum of the number that is or will be bought by the company.